All News
Filter News
Found 809,105 articles
-
Based on Failed Confirmatory Trial, FDA Adcom Recommends Pulling AMAG's Makena From the Market
10/30/2019
Makena has been approved to decrease preterm birth in pregnant women with a previous spontaneous preterm birth. -
A CRA’s Digital Journey, aka How I Learned to Love my eTMF
10/30/2019
As a consultant CRA with more than a decade of experience, I took on the assignment of managing the essential TMF documents for two large phase 3 dermatology studies in 2007 thinking “This won’t be so bad!”
-
Medigene participates at upcoming November and December 2019 conferences
10/30/2019
Martinsried/ Munich Medigene AG announces its participation at the following upcoming scientific and investor conferences.
-
DCN Dx and QIAGEN Lake Constance announce winner of the Rapid Testing Innovation Award
10/30/2019
Luminostics, Inc., to receive $10,000 cash prize and recognition from the rapid point-of-care diagnostics industry
-
Reston Hospital Center Renews Accreditation as a Center of Excellence in Minimally Invasive Gynecology
10/30/2019
Reston Hospital Center has recently renewed accreditation as a Center of Excellence in Minimally Invasive Gynecology by Surgical Review Corporation This accreditation distinguishes Reston Hospital Center from many other surgical facilities by providing the highest quality of care to patients as determined by an independent, external process of evaluation.
-
Carestream Previews Innovative Digital Tomosynthesis at RSNA
10/30/2019
Carestream will introduce a three-dimensional extension of general radiography through its Digital Tomosynthesis functionality clearance) at this year’s Radiological Society of North America conference in booth #7513, North Hall..
-
SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carna's Kinase Inhibitor
10/30/2019
SeraNovo B.V. announced that it has signed a License Agreement with Carna Biosciences, Inc., a company engaged in drug development specializing in the development of kinase inhibitors.
-
8th Annual eCOA Forum Hosted by Signant Health to Convene Clinical Operations and Outcomes Research Leaders Guiding the Future of Patient-Centric Technology
10/30/2019
Lilly, Otsuka, AbbVie, Sanofi, Sage Therapeutics to join keynote speakers, clinical research sites and patient advocates to discuss essential topics in eCOA, eConsent, patient engagement, virtual trials, sensors and wearables, AI and machine learning
-
Rho Experts Share Best Practices to Improve Diversity in Clinical Trials
10/30/2019
Free webinar provides solutions to bridge the gap between underrepresented communities and clinical research
-
ORYX Announces Positive Phase I/IIa Data for Oncolytic Virus ParvOryx Demonstrating Safety, Anti-tumor Effects, Partial Responses and Prolonged Overall Survival in Metastatic, Inoperable Pancreatic Cancer
10/30/2019
ORYX, a translational medicine company focused on oncolytic virotherapy and cancer vaccines, today published positive clinical trial results from a dose-escalating Phase I/IIa trial with oncolytic virus ParvOryx in metastatic, inoperable pancreatic cancer.
-
Evonik and Dow develop industrial-scale direct synthesis of propylene glycol from propylene and hydrogen peroxide
10/30/2019
Dow and Evonik have entered into an exclusive technology partnership. Together, they plan to bring a unique method for directly synthesizing propylene glycol (PG) from propylene and hydrogen peroxide to market maturity.
-
Evonetix expands facilities and relocates to central Cambridge, UK
10/30/2019
15,000 sq. ft of laboratory and office space at Coldham’s Business Park will enable continued growth and development of the Company’s integrated desktop platform for DNA synthesis
-
LEO Pharma announces agreement with Ubiquigent to access novel compounds
10/30/2019
Ubiquigent Limited and LEO Pharma A/S announced that they have entered into an option agreement granting LEO Pharma access to two novel compounds.
-
TSI Reports Enrollment of First 10 Patients in its Phase 2 Ischemic Stroke Clinical Trial and Completion of its Phase 2 Study Protocol in Myocardial Infarction
10/30/2019
Studies Aim to Confirm Safety and Efficacy of Novel Bio-inspired Clot-dissolving Therapy
-
Alfa Chemistry Launched Microalgae Powder Services
10/30/2019
Alfa Chemistry announced that it has launched microalgae powder production services.
-
Pelican BioThermal Among the Inaugural Class of Manufacturing Excellence Award Winners Named by Twin Cities Business Magazine
10/30/2019
Pelican BioThermal recognized alongside Minnesota manufacturing powerhouses H.B. Fuller, Mercury Mosaics, Smude Enterprises and Starkey Hearing Technologies.
-
Tell your story even better with Imaris
10/30/2019
Imaris 9.5: Insightful Rendering and Native Distance Measurements
-
Exelixis Announces Third Quarter 2019 Financial Results and Provides Corporate Update
10/30/2019
Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the third quarter of 2019 and provided an update on progress toward fulfilling its key corporate objectives, as well as commercial and clinical development milestones.
-
Innoviva Reports Third Quarter 2019 Financial Results
10/30/2019
Innoviva, Inc. (NASDAQ: INVA) (the “Company”) today reported financial results for the third quarter ended September 30, 2019.
-
Masimo Reports Third Quarter 2019 Financial Results
10/30/2019
Masimo (NASDAQ: MASI) today announced its financial results for the third quarter ended September 28, 2019.